PITCH - Impacting Hereditary Cancer Testing

Not Applicable

Not yet recruiting

• Conditions: Ovarian Cancer; Genetic Testing; Genetic Counseling

• Registration Number: NCT07090109
• Lead Sponsor: Rachel Miller

Brief Summary

The goal of this clinical trial is to assess patients' knowledge and attitudes about genetic testing before and after viewing an educational video. The main questions it aims to answer are:

* Did the video change participants' knowledge and attitudes about genetic testing?

* Did participants make an informed choice about pursuing genetic testing?

Participants will:

* Complete a baseline survey

* View educational video

* Complete follow-up survey

Detailed Description

Not available

Study Timeline

• Status Verified: 2025-07
• Study First Submitted: 2025-07-22
• Study First Submitted QC: 2025-07-22
• Last Update Submitted: 2025-07-22
• Study First Posted: 2025-07-29
• Last Update Posted: 2025-07-29
• Study Start: 2025-12-01
• Primary Completion: 2026-06
• Study Completion: 2026-06-01

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: Female
• Target Recruitment: 200

Inclusion Criteria

• diagnosed with a cancer that can be associated with hereditary forms of cancer

Exclusion Criteria

• previously undergone multi-gene panel testing for hereditary cancers

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Change in Multi-Dimensional Measure of Informed Choice (MMIC) - Cancer Knowledge Scale	Baseline and post intervention (approximately 30 minutes)	The MMIC is a compound assessment tool with three elements which are used together to differentiate an informed choice from a less informed choice. An informed choice is demonstrated by: Achieving =75% (6 of 8 questions) correct responses on the knowledge scale AND Making a decision that is in keeping with one's values related to the outcome (positive vs. negative) A less informed choice is demonstrated by: Achieving \<75% correct responses on the knowledge scale OR Achieving =75% correct responses on the knowledge scale but making a decision that is inconsistent with one's values (e.g., a patient values the information that may be obtained but chose not to undergo testing OR a patient does not value the information and chose to undergo testing)

Secondary Outcome Measures

Name	Time	Method
Number of participants completing genetic testing	90 days	Number of participants that complete testing after the intervention

Trial Locations

Locations (1)

University of Kentucky; 🇺🇸 Lexington, Kentucky, United States